Shanghai Kaibao Pharmaceutical CO.,Ltd (300039.SZ)
CNY 6.63
(0.45%)
CNY 6.63
(0.45%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 546.81 Million CNY | 9.75% |
| 2022 | 498.24 Million CNY | 60.25% |
| 2021 | 310.9 Million CNY | 4.0% |
| 2020 | 298.95 Million CNY | 9.51% |
| 2019 | 273 Million CNY | 4.1% |
| 2018 | 262.25 Million CNY | -16.55% |
| 2017 | 314.25 Million CNY | -4.07% |
| 2016 | 327.6 Million CNY | -22.21% |
| 2015 | 421.15 Million CNY | 80.97% |
| 2014 | 232.72 Million CNY | 41.29% |
| 2013 | 164.71 Million CNY | 15.76% |
| 2012 | 142.28 Million CNY | 20.61% |
| 2011 | 117.97 Million CNY | -11.56% |
| 2010 | 133.38 Million CNY | -33.04% |
| 2009 | 199.19 Million CNY | 93.49% |
| 2008 | 102.95 Million CNY | 21.63% |
| 2007 | 84.64 Million CNY | 17.89% |
| 2006 | 71.79 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 507.29 Million CNY | -7.23% |
| 2024 Q3 | 472.88 Million CNY | 2.77% |
| 2024 Q2 | 460.15 Million CNY | -9.29% |
| 2023 FY | 546.81 Million CNY | 9.75% |
| 2023 Q1 | 642.77 Million CNY | 29.01% |
| 2023 Q4 | 546.81 Million CNY | -5.83% |
| 2023 Q3 | 580.66 Million CNY | -9.14% |
| 2023 Q2 | 639.06 Million CNY | -0.58% |
| 2022 Q2 | 545.2 Million CNY | 32.35% |
| 2022 Q3 | 460.96 Million CNY | -15.45% |
| 2022 Q4 | 498.24 Million CNY | 8.09% |
| 2022 Q1 | 411.94 Million CNY | 32.5% |
| 2022 FY | 498.24 Million CNY | 60.25% |
| 2021 FY | 310.9 Million CNY | 4.0% |
| 2021 Q2 | 278.94 Million CNY | -4.71% |
| 2021 Q3 | 249.51 Million CNY | -10.55% |
| 2021 Q4 | 310.9 Million CNY | 24.6% |
| 2021 Q1 | 292.73 Million CNY | -2.08% |
| 2020 Q3 | 294.59 Million CNY | 5.55% |
| 2020 Q1 | 320.8 Million CNY | 17.51% |
| 2020 Q4 | 298.95 Million CNY | 1.48% |
| 2020 FY | 298.95 Million CNY | 9.51% |
| 2020 Q2 | 279.11 Million CNY | -13.0% |
| 2019 FY | 273 Million CNY | 4.1% |
| 2019 Q1 | 346.85 Million CNY | 32.26% |
| 2019 Q4 | 273 Million CNY | 13.32% |
| 2019 Q3 | 240.92 Million CNY | -22.96% |
| 2019 Q2 | 312.73 Million CNY | -9.84% |
| 2018 Q2 | 328.19 Million CNY | -14.87% |
| 2018 Q3 | 290.89 Million CNY | -11.37% |
| 2018 FY | 262.25 Million CNY | -16.55% |
| 2018 Q4 | 262.25 Million CNY | -9.84% |
| 2018 Q1 | 385.51 Million CNY | 22.67% |
| 2017 Q4 | 314.25 Million CNY | -6.61% |
| 2017 FY | 314.25 Million CNY | -4.07% |
| 2017 Q3 | 336.49 Million CNY | -1.55% |
| 2017 Q2 | 341.79 Million CNY | -6.04% |
| 2017 Q1 | 363.74 Million CNY | 11.03% |
| 2016 FY | 327.6 Million CNY | -22.21% |
| 2016 Q3 | 381.31 Million CNY | -5.3% |
| 2016 Q2 | 402.66 Million CNY | -9.88% |
| 2016 Q1 | 446.83 Million CNY | 6.1% |
| 2016 Q4 | 327.6 Million CNY | -14.08% |
| 2015 FY | 421.15 Million CNY | 80.97% |
| 2015 Q1 | 326.15 Million CNY | 40.15% |
| 2015 Q4 | 421.15 Million CNY | -4.43% |
| 2015 Q3 | 440.69 Million CNY | -15.96% |
| 2015 Q2 | 524.36 Million CNY | 60.77% |
| 2014 Q3 | 234.2 Million CNY | 12.83% |
| 2014 Q2 | 207.56 Million CNY | 7.14% |
| 2014 FY | 232.72 Million CNY | 41.29% |
| 2014 Q1 | 193.73 Million CNY | 17.62% |
| 2014 Q4 | 232.72 Million CNY | -0.63% |
| 2013 Q2 | 212.1 Million CNY | 4.03% |
| 2013 Q4 | 164.71 Million CNY | -24.47% |
| 2013 FY | 164.71 Million CNY | 15.76% |
| 2013 Q1 | 203.88 Million CNY | 43.29% |
| 2013 Q3 | 218.08 Million CNY | 2.82% |
| 2012 Q3 | 186.68 Million CNY | 37.94% |
| 2012 Q2 | 135.33 Million CNY | -20.9% |
| 2012 Q4 | 142.28 Million CNY | -23.78% |
| 2012 FY | 142.28 Million CNY | 20.61% |
| 2012 Q1 | 171.1 Million CNY | 45.04% |
| 2011 FY | 117.97 Million CNY | -11.56% |
| 2011 Q4 | 117.97 Million CNY | -4.88% |
| 2011 Q3 | 124.02 Million CNY | -0.05% |
| 2011 Q1 | 124.78 Million CNY | -6.45% |
| 2011 Q2 | 124.08 Million CNY | -0.56% |
| 2010 Q4 | 133.38 Million CNY | 9.57% |
| 2010 Q1 | 64.47 Million CNY | -67.64% |
| 2010 Q2 | 73.74 Million CNY | 14.39% |
| 2010 Q3 | 121.73 Million CNY | 65.07% |
| 2010 FY | 133.38 Million CNY | -33.04% |
| 2009 FY | 199.19 Million CNY | 93.49% |
| 2009 Q4 | 199.19 Million CNY | 1.02% |
| 2009 Q3 | 197.18 Million CNY | 42.82% |
| 2009 Q2 | 138.06 Million CNY | 0.0% |
| 2008 FY | 102.95 Million CNY | 21.63% |
| 2008 Q4 | 102.95 Million CNY | 0.0% |
| 2007 FY | 84.64 Million CNY | 17.89% |
| 2006 FY | 71.79 Million CNY | 0.0% |